It has been proven that ECT2 also promotes cervical cancer progression by regulating the AKT/mTOR pathway, and the expression levels of p-AKT and p-mTOR are also significantly increased in cells overexpressing ECT2, while the opposite is true for underexpressing ECT2. This evidence concerns the gene AKT1 and cervical carcinoma.